Continue reading >
Charlottesville, Va., October 13, 2021 – In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto, Canada, have demonstrated that magnetic resonance (MR)-guided focused ultrasound can be used to safely deliver antibody therapy to breast cancer that has metastasized to the brain.
The 2021 American Urological Association (AUA) Annual Meeting was held September 10-13, 2021.
On September 7-10, 2021, iTRUSST held its 2nd Focused Ultrasound Neuromodulation (FUN) Symposium as an online conference originating from the University of Oxford, UK.
The IEEE International Ultrasonics Symposium (IUS) 2021 was held as a virtual meeting September 11-16, 2021.
The Cardiovascular and Interventional Radiology Society of Europe (CIRSE) 2021 Summit was held virtually September 25-28, 2021.
Parkinson’s Disease (PD) is a neurodegenerative brain disease that is progressively debilitating and leads to motor dysfunction and cognitive decline. PD affects more than 10 million people worldwide and nearly 1 million in the US. Healthcare costs in the US alone related to PD are estimated at $52 billion per year.
The first patient has been treated in a new phase I/II clinical trialfor patients with recurrent glioblastoma (GBM). Researchers at Northwestern University in Chicago will recruit up to 39 patients to have CarThera’s SonoCloud-9 implanted after surgical removal of the tumor, as it will be used to temporarily open the blood-brain barrier (BBB) prior to the administration of chemotherapy.
A complicated process like using focused ultrasound plus microbubbles to modulate the permeability of the blood-brain barrier (BBB) is not easy to describe. Now, with the availability of advanced digital tools and technologies, the biomedical visualization field is allowing talented young artists with an interest in medicine and an understanding of cellular and molecular biology in addition to anatomy to develop new visual communication tools to help scientists graphically share their discoveries.
Elisa Konofagou, PhD, the Robert and Margaret Hariri Professor of Biomedical Engineering and Radiology at Columbia University, and her research team recently treated the first patient in their clinical trial to open the blood-brain barrier (BBB) in patients with Alzheimer’s disease.
β-Amyloid Plaque Reduction in the Hippocampus After Focused Ultrasound-Induced Blood–Brain Barrier Opening in Alzheimer’s DiseaseA collaborative research group from West Virginia University, Vanderbilt University, and Weill Cornell Medical College measured the beta-amyloid plaque changes in six patients with Alzheimer’s disease who underwent multiple sessions of focused ultrasound—based blood brain barrier (BBB) opening.
The focused ultrasound research community is actively pursuing the treatment of various stages of breast cancer in nine ongoing clinical trials worldwide.
Researchers in Switzerland have developed a novel neuromodulation sequence for aggregating and uncaging drug carriers at a circuit-specific location in the brain.
On September 15, 2020, the Focused Ultrasound Foundation helped sponsor the Breast Cancer Alliance’s annual Medical Symposium: Hot Topics in Breast Cancer.
The IEEE International Ultrasonics Symposium (IUS) took place virtually September 6–11, 2020. The international group of more than 1,900 ultrasound experts and researchers watched live lectures and prerecorded abstract presentations, attended interactive poster sessions, and enrolled in a wide variety of virtual webinars and workshops.
A new undergraduate seminar course in the Biomedical Engineering department at the University of Virginia will introduce students to focused ultrasound therapy.
On July 14, graduate student Natasha Sheybani successfully defended her dissertation to earn a PhD from the Department of Biomedical Engineering in the University of Virginia (UVA) School of Engineering & Applied Science. “Leveraging Focused Ultrasound to Potentiate Immunotherapy for Primary and Disseminated Solid Tumors” was the accumulation of five years spent studying the use of focused ultrasound for cancer immunotherapy.
Denmark-based TOOsonix recently announced the publication of two peer-reviewed studies. One paper found the company’s novel device to be successful in treating skin lesions, including cancer; the other announced results for tattoo ink removal in problematic cases. Read on to learn how TOOsonix is able to use focused ultrasound to treat various depths in the skin without thermal injury to the adjacent, non-target tissue.
The 42nd Annual International Conference of the IEEE Engineering in Medicine and Biology (EMBC) Society and the 43rd Annual Conference of the Canadian Medical and Biological Engineering Society were held July 20–24, 2020.
On July 23, the International Society for Therapeutic Ultrasound (ISTU) broadcasted the next installment in its new series of “ISTU On Air’ webinars.
Neurologist Prof. José Obeso has built a large research and clinical practice centered on using focused ultrasound to halt the progression of Parkinson’s and other brain diseases.
Dr. Craig Slingluff is a University of Virginia Professor of Surgery who is conducting a clinical trial to study the effects of focused ultrasound with or without a cancer immunotherapy drug (pembrolizumab or imiquimod) to treat advanced solid tumors.
The Foundation established a dedicated Cancer Immunotherapy Program in 2015, with a mission to explore the potential of focused ultrasound in the cancer immunotherapy field. As part of this program, the Foundation invites funding applications for collaborative projects that address key questions driving the field.
Page 1 of 6